Decoding IgA Nephropathy: From Suspicion to Solution
Jonathan Barratt, MD, PhD
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Translating Evidence into IgAN Care
The Evolving Role of Biomarkers in IgAN
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Nancy Helou, PhD
Gabapentinoids: Safety Considerations and Downstream Outcomes
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
What You Don’t See: A Patient’s View of Living with CKD-aP
PSVT Without the Panic: Structured Care That Works
September 16, 2026
Optimizing Outcomes in Patients with FSGS: A Case-Based Approach in the New Era of Targeted Therapy
Sayna Norouzi, MD
Crossing Home Plate – Building a Winning Team Culture
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
ASCVD Playbook | Closing the Gaps, One Inning at a Time
Swing for the Fences – LDL-C as the Power Hitter
Leadoff Hitter – Spotting High-Risk Players
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD